Corsico, Italy

Mario Faretta


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Mario Faretta

Introduction: Mario Faretta is a distinguished inventor based in Corsico, Italy, known for his significant contributions in the field of medical therapy. With an impressive patent to his name, Fairetta has dedicated his research efforts towards advancing diagnostic tools that enhance treatment efficacy for various disorders.

Latest Patents: Mario Faretta holds a noteworthy patent titled "Antibody tools for the diagnostic use in the medical therapy with inhibitors of histone deacetylases." This innovative method enables the determination of whether a treatment involving HDAC inhibitors should be initiated or continued. By analyzing the level of histone acetylation in a sample through an antibody that specifically binds to acetylated histones, Faretta's invention categorizes the disorder as treatable with the inhibitor when the acetylation level is significantly lower than a reference sample. Additionally, it extends its utility to diagnostic and prognostic applications utilizing specific antibodies and cell lines that produce them.

Career Highlights: Mario Faretta currently contributes his expertise at Topotarget Germany AG, a company at the forefront of developing innovative therapies for cancer treatment. His commitment to research and development has solidified his reputation as an important figure in medical innovation.

Collaborations: Throughout his career, Faretta has collaborated with notable colleagues such as Giuseppe Pier Pelicci and Saverio Minucci. These partnerships foster a collaborative environment conducive to groundbreaking advances in medical science and innovation.

Conclusion: Mario Faretta's inventive spirit and dedication to enhancing diagnostic tools have the potential to significantly impact medical therapy practices. His work, particularly in the use of antibody tools in conjunction with histone deacetylase inhibitors, promises to facilitate better treatment strategies for patients while highlighting the importance of innovation in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…